Admedus Ltd Rights 22-Aug-16 (AHZR) Short Interest
Admedus Ltd Rights 22-Aug-16 (ASX:AHZR) had 0.22% of shares reported as short positions as of 12 Sept 2016, representing 56,501 shares. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Admedus Ltd Rights 22-Aug-16
Admedus Ltd is a healthcare company specializing in the development and commercialization of medical devices and technologies. The company focuses on providing innovative solutions in the field of biotechnology, particularly in cardiovascular health. Admedus aims to enhance patient outcomes through its proprietary tissue engineering technology.
Short position
Admedus Ltd Rights 22-Aug-16 (ASX:AHZR) has 0.22% of its shares on issue reported as short positions as of 12 Sept 2016, or about 56,501 shares. Over the past 7 days that figure has been broadly flat. Its highest recorded short interest was 1.29% in August 2016. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4AHZR intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Admedus Ltd Rights 22-Aug-16
Be the first to discuss AHZR
Start a research thread or post the first pulse update